Suppr超能文献

Ustekinumab-induced drug eruption resembling lymphocytic infiltration (of Jessner-Kanof) and lupus erythematosus tumidus.

作者信息

Guarneri Claudio, Lentini Maria, Polimeni Giovanni, Giuffrida Roberta, Cannavò Serafinella P

机构信息

Department of Clinical Experimental Medicine, Section of Dermatology, A.O.U. Policlinico 'G. Martino', University of Messina, Messina, Italy.

Department of Human Pathology, A.O.U. Policlinico 'G. Martino', University of Messina, Messina, Italy.

出版信息

Br J Clin Pharmacol. 2016 Apr;81(4):792-4. doi: 10.1111/bcp.12837. Epub 2015 Dec 29.

Abstract
摘要

相似文献

1
Ustekinumab-induced drug eruption resembling lymphocytic infiltration (of Jessner-Kanof) and lupus erythematosus tumidus.
Br J Clin Pharmacol. 2016 Apr;81(4):792-4. doi: 10.1111/bcp.12837. Epub 2015 Dec 29.
6
Lymphocytic infiltration (Jessner-Kanof): lupus erythematosus tumidus or a manifestation of borreliosis?
Br J Dermatol. 2007 Aug;157(2):403-5. doi: 10.1111/j.1365-2133.2007.07997.x. Epub 2007 Jun 15.
7
Fixed drug eruption [proceedings].
Int J Dermatol. 1979 Sep;18(7):590-2.
9
Proceedings: Bullous pemphigoid (rule out bullous lupus erythematosus and bullous drug eruption).
Arch Dermatol. 1974 Nov;110(5):820-1. doi: 10.1001/archderm.110.5.820.
10
Flare of palmoplantar psoriasis with ustekinumab.
Australas J Dermatol. 2020 Feb;61(1):63-65. doi: 10.1111/ajd.13122. Epub 2019 Aug 1.

引用本文的文献

1
An update on the management of refractory cutaneous lupus erythematosus.
Front Med (Lausanne). 2022 Sep 23;9:941003. doi: 10.3389/fmed.2022.941003. eCollection 2022.
2
Alternative uses of ustekinumab for non-indicated dermatological conditions: a systematic review.
Arch Dermatol Res. 2022 Aug;314(6):503-514. doi: 10.1007/s00403-021-02262-7. Epub 2021 Jun 22.
3
Lupus erythematosus tumidus: clinical perspectives.
Clin Cosmet Investig Dermatol. 2019 Oct 1;12:707-719. doi: 10.2147/CCID.S166723. eCollection 2019.
4
Secukinumab for psoriasis in a patient with familial Mediterranean fever.
Dermatol Ther. 2019 Nov;32(6):e13122. doi: 10.1111/dth.13122. Epub 2019 Oct 24.
5
Managing Risks with Biologics.
Curr Gastroenterol Rep. 2019 Jan 11;21(2):1. doi: 10.1007/s11894-019-0669-6.
6
A Practical Guide to the Safety and Monitoring of New IBD Therapies.
Inflamm Bowel Dis. 2019 Apr 11;25(5):831-842. doi: 10.1093/ibd/izy313.

本文引用的文献

2
Severe drug-induced dermatoses.
Semin Cutan Med Surg. 2014 Mar;33(1):49-58. doi: 10.12788/j.sder.0062.
3
Duloxetine-induced pseudolymphoma with features of lymphocytic infiltration of Jessner-Kanof.
Acta Derm Venereol. 2014 Sep;94(5):605-6. doi: 10.2340/00015555-1785.
4
Jessner-Kanof disease induced by leflunomide: a dermal variant of cutaneous lupus?
Rheumatol Int. 2011 Feb;31(2):255-8. doi: 10.1007/s00296-009-1169-z. Epub 2009 Oct 13.
7
Jessner-Kanof lymphocytic infiltration of the skin associated with glatiramer acetate.
Mult Scler. 2005 Apr;11(2):245-8. doi: 10.1191/1352458505ms1130cr.
9
Histopathologic findings in lupus erythematosus tumidus: review of 80 patients.
J Am Acad Dermatol. 2003 Jun;48(6):901-8. doi: 10.1067/mjd.2003.435.
10
A method for estimating the probability of adverse drug reactions.
Clin Pharmacol Ther. 1981 Aug;30(2):239-45. doi: 10.1038/clpt.1981.154.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验